Net Loss Per Share of Common Stock - Schedule of Diluted Net Loss Per Share (Details) - Successor [Member] - shares |
6 Months Ended | |
|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Schedule of Diluted Net Loss Per Share [Line Items] | ||
| Total antidilutive shares | 1,780,088,244 | 881,026 |
| Conversion of convertible preferred stock issued and outstanding [Member] | ||
| Schedule of Diluted Net Loss Per Share [Line Items] | ||
| Total antidilutive shares | 1,033,865,400 | 647,151 |
| Conversion of convertible notes payable [Member] | ||
| Schedule of Diluted Net Loss Per Share [Line Items] | ||
| Total antidilutive shares | 700,229,358 | |
| Exercise of warrants for common stock [Member] | ||
| Schedule of Diluted Net Loss Per Share [Line Items] | ||
| Total antidilutive shares | 159,724 | 159,724 |
| Common stock underlying outstanding options (2024 Plan) [Member] | ||
| Schedule of Diluted Net Loss Per Share [Line Items] | ||
| Total antidilutive shares | 45,833,762 | 74,151 |